Literature DB >> 30958387

Cognitive and Motor Impairment Severity Related to Signs of Subclinical Wernicke's Encephalopathy in HIV Infection.

Anne-Pascale Le Berre1, Rosemary Fama1,2, Stephanie A Sassoon2, Adolf Pfefferbaum1,2, Edith V Sullivan1, Natalie M Zahr1,2.   

Abstract

BACKGROUND: Wernicke's encephalopathy (WE) is a neurological condition resulting from thiamine deficiency. Although commonly associated with alcoholism, nonalcoholic WE has been described in individuals with HIV infection, but subclinical WE may be underdiagnosed. The current study questioned whether the presence of subclinical WE signs underlies cognitive and motor deficits in HIV individuals as observed in alcoholism.
SETTING: Fifty-six HIV-positive individuals (HIV+) and 53 HIV-negative controls (HIV-) were assessed on 6 cognitive and motor domains: attention/working memory, production, immediate and delayed episodic memory, visuospatial abilities, and upper-limb motor function.
METHODS: Based on a rating scheme by Caine et al, HIV+ individuals were categorized by subclinical WE risk factors (dietary deficiency, oculomotor abnormality, cerebellar dysfunction, and altered mental state). Performance was expressed as age- and education-corrected Z-scores standardized on controls.
RESULTS: Sorting by Caine criteria yielded 20 HIV+ as Caine 0 (ie, meeting no criteria), 22 as Caine 1 (ie, meeting one criterion), and 14 as Caine 2 (ie, meeting 2 criteria). Comparison among HIV+ Caine subgroups revealed a graded effect: Caine 0 performed at control levels, Caine 1 showed mild to moderate deficits on some domains, and Caine 2 showed the most severe deficits on each domain.
CONCLUSION: This graded severity pattern of performance among Caine subgroups suggests that signs of subclinical WE can partly explain the heterogeneity in HIV-related cognitive and motor impairment. This study highlights the utility of Caine criteria in identifying potential causes of HIV-related neurocognitive disorders and has implications for disease management.

Entities:  

Mesh:

Year:  2019        PMID: 30958387      PMCID: PMC6565459          DOI: 10.1097/QAI.0000000000002043

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  79 in total

1.  Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

Authors:  M Maschke; O Kastrup; S Esser; B Ross; U Hengge; A Hufnagel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 2.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

3.  Thiamin deficiency in HIV-positive patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate effect.

Authors:  R M Müri; J Von Overbeck; J Furrer; P E Ballmer
Journal:  Clin Nutr       Date:  1999-12       Impact factor: 7.324

4.  Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.

Authors:  Jon D Kaiser; Adriana M Campa; Joseph P Ondercin; Gifford S Leoung; Richard F Pless; Marianna K Baum
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

5.  Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.

Authors:  Karin Weissenborn; Jochen Krause; Martin Bokemeyer; Hartmut Hecker; Andreas Schüler; Jochen C Ennen; Björn Ahl; Michael P Manns; Klaus W Böker
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

6.  Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity.

Authors:  Rosemary Fama; Edith V Sullivan; Stephanie A Sassoon; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2016-10-19       Impact factor: 3.455

7.  Psychomotor slowing in hepatitis C and HIV infection.

Authors:  Hans-Jürgen von Giesen; Tobias Heintges; Naghme Abbasi-Boroudjeni; Seher Kücükköylü; Hubertus Köller; Bernhard A Haslinger; Mark Oette; Gabriele Arendt
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

Review 8.  Evolving clinical phenotypes in HIV-associated neurocognitive disorders.

Authors:  Ned Sacktor; Kevin Robertson
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 9.  Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Authors:  Eileen M Martin-Thormeyer; Robert H Paul
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

Review 10.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

View more
  3 in total

1.  Poor subjective sleep predicts compromised quality of life but not cognitive impairment in abstinent individuals with Alcohol Use Disorder.

Authors:  David Piekarski; Edith V Sullivan; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol       Date:  2022-07-21       Impact factor: 2.558

2.  Cognitive impairment severity in relation to signs of subclinical Wernicke's encephalopathy in HIV and alcoholism comorbidity.

Authors:  Anne-Pascale Le Berre; Rosemary Fama; Stephanie A Sassoon; Natalie M Zahr; Adolf Pfefferbaum; Edith V Sullivan
Journal:  AIDS       Date:  2020-03-01       Impact factor: 4.632

3.  Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.

Authors:  Mark K Britton; Eric C Porges; Vaughn Bryant; Ronald A Cohen
Journal:  Alcohol Clin Exp Res       Date:  2020-12-30       Impact factor: 3.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.